IDXX congressional trades
IDEXX Laboratories, Inc. (IDXX) appears in 17 congressional disclosure rows from 4 members of Congress in 2025–2026 periodic reports: 11 purchases and 6 sales, with trade dates from Feb 25, 2025 to Jan 13, 2026. John Delaney reported the most, with 9 rows. The median gap between trade date and filing date is 27 days, and every trade was reported within 45 days.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live IDXX portfolio or a trading signal.
- 17
- 4
- 11 / 6
- $179K – $610K
- sum of reported ranges
- 2026-01-13
Verified IDXX congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 11 purchases and 6 sales. Reported owners: Dependent, Self, Spouse. Transaction dates run from 2025-02-25 to 2026-01-13.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Sale | Dependent | $1,001 - $15,000 | #20033921 Filed 2026-02-02 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Sale | Dependent | $1,001 - $15,000 | #20033408 Filed 2025-11-04 | |
| Byron Donalds | IDEXX Laboratories, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20032234 Filed 2025-10-07 | |
| Byron Donalds | IDEXX Laboratories, Inc. - Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032234 Filed 2025-10-07 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Sale | Dependent | $1,001 - $15,000 | #20031013 Filed 2025-09-02 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Sale | Dependent | $1,001 - $15,000 | #20030832 Filed 2025-08-05 | |
| Robert Bresnahan | IDEXX Laboratories, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20030482 Filed 2025-06-09 | |
| Jefferson Shreve | IDEXX Laboratories, Inc. - Common Stock | Sale | Self | $100,001 - $250,000 | #20030387 Filed 2025-06-22 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20030265 Filed 2025-05-02 | |
| Robert Bresnahan | IDEXX Laboratories, Inc. - Common Stock | Sale | Self | $1,001 - $15,000 | #20030238 Filed 2025-04-28 | |
| Jefferson Shreve | IDEXX Laboratories, Inc. - Common Stock | Purchase | Self | $50,001 - $100,000 | #20030231 Filed 2025-05-08 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20030265 Filed 2025-05-02 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20030265 Filed 2025-05-02 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20030265 Filed 2025-05-02 | |
| John Delaney | IDEXX Laboratories, Inc. - Common Stock | Purchase | Dependent | $1,001 - $15,000 | #20029059 Filed 2025-04-02 | |
| Jefferson Shreve | IDEXX Laboratories, Inc. - Common Stock | Purchase | Self | $15,001 - $50,000 | #20029038 Filed 2025-04-11 | |
| Robert Bresnahan | IDEXX Laboratories, Inc. - Common Stock | Purchase | Self | $1,001 - $15,000 | #20029034 Filed 2025-03-27 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
IDXX disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| John Delaney's IDXX trades | 9 | 5 | 4 | 2026-01-13 |
| Jefferson Shreve's IDXX trades | 3 | 2 | 1 | 2025-05-12 |
| Robert Bresnahan's IDXX trades | 3 | 2 | 1 | 2025-05-15 |
| Byron Donalds | 2 | 2 | 0 | 2025-09-04 |
How long disclosure took
Days from trade date to filing date for 17 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 12
- 31–45 days
- 5
- Over 45 days
- 0
- Median / longest
- 27d / 41d
Source documents
13 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #20033921Filed 2026-02-02 · 1 row
- #20033408Filed 2025-11-04 · 1 row
- #20032234Filed 2025-10-07 · 2 rows
- #20031013Filed 2025-09-02 · 1 row
- #20030832Filed 2025-08-05 · 1 row
- #20030387Filed 2025-06-22 · 1 row
- #20030482Filed 2025-06-09 · 1 row
- #20030231Filed 2025-05-08 · 1 row
- #20030265Filed 2025-05-02 · 4 rows
- #20030238Filed 2025-04-28 · 1 row
- #20029038Filed 2025-04-11 · 1 row
- #20029059Filed 2025-04-02 · 1 row
1 older filings are linked from the transaction table.
What IDXX filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
- IDEXX Laboratories, Inc. financials and filings
Audited SEC figures, what moves IDXX, and primary sources.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
IDXX congressional trades: FAQ
Who in Congress traded IDXX?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 17 verified IDXX rows from 4 members: Byron Donalds, Jefferson Shreve, John Delaney, and Robert Bresnahan. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current IDXX holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are IDXX amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $100,001 - $250,000; $50,001 - $100,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is IDXX congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (178 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded IDXX.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-03. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported IDXX and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included